ANURAS Q3 FY26 Earnings Call Transcript & Analysis
9MFY26 Revenue ₹1,730 cr (+84% YoY); 9MFY26 EBITDA ₹402 cr (+53% YoY); 9MFY26 PAT ₹166 cr (+71% YoY). 9MFY26 consolidated revenue of INR1,730 crores, up 84% YoY.
Read full transcript & analysis
Every earnings call for ANURAS — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ANURAS · 5 transcripts · Chemicals · latest Q3 FY269MFY26 Revenue ₹1,730 cr (+84% YoY); 9MFY26 EBITDA ₹402 cr (+53% YoY); 9MFY26 PAT ₹166 cr (+71% YoY). 9MFY26 consolidated revenue of INR1,730 crores, up 84% YoY.
Read full transcript & analysisJayhawk Revenue (CY24) 78 million; Jayhawk EBITDA Margin (CY24) 19%; Combined Pro-forma Revenue 243 million. Acquisition of Jayhawk Fine Chemicals strengthens global specialty footprint and provides direct US manufacturing presence.
Read full transcript & analysisRevenue (H1 FY26) ₹1,217 cr (+122% YoY); EBITDA (H1 FY26) ₹273 cr (+93% YoY); EBITDA Margin (H1 FY26) 22.2%. Consolidated revenue of ₹731.4 crore in Q2 FY26, up 148.8% YoY.
Read full transcript & analysisOperating Revenue (Q4 FY25) ₹500 cr (+25% YoY); EBITDA (Q4 FY25) ₹150 cr (+43% YoY); EBITDA Margin (Q4 FY25) 30.0%. Q4 FY25 consolidated operating revenue at INR500 crores, up 22% Y-o-Y and 31% Q-o-Q.
Read full transcript & analysisOperating Revenue (Q3 FY25) ₹390 cr (+32% YoY); EBITDA (Q3 FY25) ₹121 cr (+48% YoY); EBITDA Margin (Q3 FY25) 31%. Consolidated operating revenue grew 32% YoY to INR 390 crores in Q3 FY25.
Read full transcript & analysis